Latest News

Date Title Topic
05 Oct 2017 Therapeutic Targeting of p53 Translational research
04 Oct 2017 FDA Grants Accelerated Approval to Nivolumab for HCC Previously Treated With Sorafenib Gastrointestinal cancers - Cancer Immunology and Immunotherapy
03 Oct 2017 FDA Grants Accelerated Approval to Copanlisib for Relapsed Follicular Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
02 Oct 2017 FDA Approves Abemaciclib for HR-positive, HER2-negative Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
29 Sep 2017 EMA Recommends Granting a Marketing Authorisation for Padeliporfin Genitourinary cancers
28 Sep 2017 NICE Develops a Medtech Innovation Briefing on Caris Molecular Intelligence for Guiding Cancer Treatment Personalised medicine
eUpdate – Treatment Recommendation
27 Sep 2017 FDA Approves Lower Dose of Cabazitaxel for mCRPC Genitourinary cancers - Anticancer agents & Biologic therapy
25 Sep 2017 FDA Grants Accelerated Approval to Pembrolizumab for Advanced Gastric Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
25 Sep 2017 How To Overcome EGFR Mutation Resistance In Lung Cancer Lung and other thoracic tumours
25 Sep 2017 EMA Recommends Extensions of Therapeutic Indications for Nilotinib Haematologic malignancies - Cancer in Special Situations - Anticancer agents & Biologic therapy
Programme
22 Sep 2017 EMA Recommends Granting a Marketing Authorisation for Generic Imatinib Sarcomas - Haematologic malignancies - Anticancer agents & Biologic therapy
Programme
Abstracts